Access to medicines and treatment: latest news

Access to medicines and treatment resources

Access to medicines and treatment features

Access to medicines and treatment news from aidsmap

More news

Access to medicines and treatment news selected from other sources

  • Gilead Continues To Block Ireland From Sourcing Generic Truvada

    Gilead Sciences, the company that supplies Ireland with the drug Truvada, will have a full court hearing in mid-October to determine whether the Irish Health and Safety Executive (HSE) can source a generic analogue of the drug from the pharmaceutical giant’s competitors. In July, GCN reported that Gilead was taking legal action to stop the HSE from securing generic drug from Actavis and Mylan, the company’s competitors, for the purposes of HIV prevention as PrEP.

    16 October 2017 | Gay Community News
  • STI warning as clinics close in London and self-testing is delayed

    People are being denied care at overburdened sexual health clinics after a wave of closures and huge delays to a controversial new self-testing scheme for diseases such as herpes and syphilis, health experts are warning.

    16 October 2017 | The Guardian
  • New report details health crisis in Venezuela

    Venezuela is in the middle of an unprecedented, statemade, complex humanitarian emergency with severe and widespread social consequences. Its AIDS program, once lauded as a model, has collapsed, with chronic drug shortages and the lack of condoms or diagnostic tests putting thousands at risk of preventable diseases and death.

    16 October 2017 | ICASO
  • Doctors Are Worried That NHS Charges Will Stop Vulnerable Patients Getting The Treatment They Need

    Overseas patients will soon be legally required to pay upfront for some NHS treatments, which many professionals say will get in the way of treating them safely.

    13 October 2017 | BuzzFeed
  • Moscow Buyers Club: Russia's AIDS Patients Work Together To Overcome Medication Shortages

    Problems with the distribution of HIV/AIDS medications have become endemic in Russia, forcing patients to increasingly rely on one another to get the treatments they need. The situation in Russia in 2017 has come to resemble the plot of the Hollywood movie Dallas Buyers Club, which was set in the United States in the 1980s.

    09 October 2017 | Radio Free Europe
  • Hepatitis C Drug’s Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment

    Valerie Green is still waiting to be cured. The Delaware resident was diagnosed with hepatitis C more than two years ago, but she doesn’t qualify yet for the Medicaid program’s criteria for treatment with a new class of highly effective but pricey drugs. The recent approval of a less expensive drug that generally cures hepatitis C in just eight weeks may make it easier for more insurers and correctional facilities to expand treatment.

    05 October 2017 | Kaiser Health News
  • The Medicines Patent Pool and Gilead Sciences Sign Licence for Bictegravir

    The Medicines Patent Pool (MPP) today announced a licence with Gilead Sciences for bictegravir (BIC), now under review in the United States and the European Union as part of a once-daily, single-tablet HIV regimen. The licence allows manufacturers to develop and sell generic medicines containing BIC, if approved in the United States, in 116 low- and middle-income countries where more than 30 million people live with HIV.

    04 October 2017 | Medicines Patent Pool
  • Protesters stage London demo against plans for patient ID checks

    Critics fear checks will destroy relationship NHS staff have with patients and create climate of fear that stops people accessing care

    02 October 2017 | The Guardian
  • Nigeria: Govt to Provide ARV for 50,000 Additional People Living With HIV Yearly

    The Nigerian government has made new commitments to use domestic funds to provide antiretroviral drugs to an additional 50,000 people living with Human Immuno Virus (HIV) each year in the country.

    29 September 2017 | AllAfrica
  • Achieving National HIV/AIDS Strategy targets would save lives, be cost effective

    An analysis led by a team of Massachusetts General Hospital investigators shows that achieving the treatment targets of the National HIV/AIDS Strategy by 2020 not only would prevent hundreds of thousands of new infections and deaths but also would demonstrate excellent value.

    28 September 2017 | Eurekalert Inf Dis
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.